0000904454-24-000253.txt : 20240410
0000904454-24-000253.hdr.sgml : 20240410
20240410170542
ACCESSION NUMBER: 0000904454-24-000253
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240409
FILED AS OF DATE: 20240410
DATE AS OF CHANGE: 20240410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42001
FILM NUMBER: 24836520
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson & Johnson Innovation - JJDC, Inc.
CENTRAL INDEX KEY: 0000924020
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42001
FILM NUMBER: 24836519
BUSINESS ADDRESS:
STREET 1: 410 GEORGE STREET
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08901
BUSINESS PHONE: (732) 524-3218
MAIL ADDRESS:
STREET 1: 410 GEORGE STREET
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08901
FORMER NAME:
FORMER CONFORMED NAME: JOHNSON & JOHNSON DEVELOPMENT CORP ET AL
DATE OF NAME CHANGE: 19940526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Contineum Therapeutics, Inc.
CENTRAL INDEX KEY: 0001855175
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271467257
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 333-5280
MAIL ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Pipeline Therapeutics, Inc.
DATE OF NAME CHANGE: 20210405
3
1
ownership.xml
X0206
3
2024-04-09
0
0001855175
Contineum Therapeutics, Inc.
CTNM
0000200406
JOHNSON & JOHNSON
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK
NJ
08933
0
0
1
0
0000924020
Johnson & Johnson Innovation - JJDC, Inc.
410 GEORGE STREET
NEW BRUNSWICK
NJ
08901
0
0
1
0
Class A Common Stock
1979173
I
See footnote
The securities reported as indirectly beneficially owned by Johnson & Johnson are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of Johnson & Johnson.
Johnson & Johnson By: /s/ Marc Larkins, Secretary
2024-04-10
Johnson & Johnson Innovation - JJDC, Inc. By: /s/ Jill McManus, Assistant Treasurer
2024-04-10